newsfilter
← Latest News
GlobeNewswire·

Avicanna Completes First Delivery of Proprietary Topical Products to Multinational Pharmaceutical Company

TORONTO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or the "Company") (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN), a commercial stage, international biopharmaceutical company focused on the commercialization